Metabolic & Cardiometabolic
resistant starch improves insulin resistance
In plain terms: Does resistant starch help your body handle blood sugar?
Part of: 🧪 resistant starch
Probably yes — a modest benefit, mainly in people who already have insulin resistance.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
RS modestly improves HOMA-IR and metabolic markers, concentrated in insulin-resistant/MetS populations.
The evidence (20)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Bergeron 2016 · Br J Nutr | RCT | contradicts | moderate | 2-wk high-RS diet did not improve fasting glucose, insulin or lipids; raised TMAO under low-carb |
| Kim HR et al 2026 · study_type: animal | animal | contradicts | low | Duplicate/earlier posting of RS5 (rice-starch beta-limit dextrin-lauric acid) mouse study: no significant OGTT or insulin-resistance change after 5wk supplementation. |
| Zeng J et al 2026 · study_type: animal | animal | supports | moderate | RS-rich rice varieties (RSRR), HFD-induced T2D mice, 6wk: reduced fasting glucose, serum insulin, and improved insulin resistance vs common-rice control; KTD variety most effective. |
| Gao 2019 · Lipids Health Dis | meta-analysis | mixed | moderate | SR/MA: resistant starch ameliorated insulin resistance (HOMA-IR) in patients with type 2 diabetes and obesity. |
| Suárez-Diéguez T et al 2025 · study_type: animal | animal | supports | low | Retrograded RS (RS3, faba bean-derived) 15-30% diet replacement, diabetic Wistar rats: ~29% lower postprandial hyperglycemia, 22% lower fasting glucose, lower insulin-resistance index; no lipid/oxidative-stress effect. |
| Schioldan 2018 · Eur J Nutr | RCT | mixed | moderate | Arabinoxylan+RS diet improved some postprandial metabolic features of metabolic syndrome vs refined carbohydrate, with limited IR change. |
| Karimi 2016 · Ann Nutr Metab | RCT | supports | moderate | RS2 improved glycemic status and reduced insulin resistance, endotoxemia and oxidative stress in women with T2D. ↩ SUPERSEDED — pooled in the review above, counted once |
| King 2025 · Clin Nutr ESPEN | RCT | supports | moderate | 12-wk sago RS2 improved glycemic and lipid control in type 2 diabetes (double-blind RCT). |
| Costa 2019 · Br J Nutr | RCT | supports | moderate | Green-banana-biomass RS lowered HbA1c, fasting glucose and HOMA-IR in pre-diabetes/T2D over 24 weeks. |
| Robertson 2005 · Am J Clin Nutr | RCT | supports | moderate | Dietary RS improved peripheral insulin sensitivity and modulated skeletal-muscle/adipose metabolism in healthy adults. ↩ SUPERSEDED — pooled in the review above, counted once |
| Snelson 2019 2019 · Nutrients | meta-analysis | contradicts | high | 22-RCT meta-analysis: RS2 lowered triglycerides but showed no consistent improvement in fasting glucose, HbA1c or insulin resistance. |
| Dainty 2016 · J Nutr | RCT | supports | moderate | HAM-RS2 bagels reduced fasting and postprandial insulin in adults at risk of T2D ↩ SUPERSEDED — pooled in the review above, counted once |
| Xiong K, et al. 2021 · Br J Nutr | meta-analysis | supports | moderate | [FT-verified] 19 RCTs FPG -0.09 mmol/L; larger >28g/d; modest dose-dependent |
| Jaroenporn S et al 2026 · study_type: animal | animal | contradicts | moderate | Cassava RS3 in isocaloric HFD, healthy Wistar rats 28d: fasting glucose, insulin, and lipids statistically unchanged vs HFD-native-starch; only modest early glucose-tolerance improvement. |
| White 2020 · J Acad Nutr Diet | RCT | tested-null | moderate | RS2 had no effect on appetite/food intake in prediabetes; part of STARCH program testing diabetes risk factors. |
| Miralles-Pérez B et al 2025 · study_type: animal | animal | contradicts | moderate | RS2 (15%, high-amylose maize) in HFD, male Wistar rats, 10wk: improved glucose tolerance but did NOT significantly affect insulin sensitivity vs HFD control. |
| Halajzadeh J, et al. 2020 · Crit Rev Food Sci Nutr | meta-analysis | supports | moderate | [FT-verified] 19 trials MetS FPG -4.28 mg/dL insulin -1.95 HbA1c -0.60%; small consistent |
| Park 2023 · Nutrients | RCT | supports | moderate | High-RS brown rice (Dodamssal) reduced HOMA-IR vs low-RS rice in obese participants. |
| Im ST et al 2026 · study_type: animal | animal | supports | moderate | RS-enriched high-amylose rice (R-HAR), HFD obese mice: markedly reduced fasting insulin & HOMA-IR vs HFD control, dose-dependent, alongside lower fasting glucose; no CIs given. |
| Garcia-Vazquez 2023 · Eur J Nutr | RCT | mixed | moderate | RS improved acute glycemic response in T2D but chronic IR benefit not established |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.